IP Library Granted Patent US 9,816,082
Granted Patent B2
US 9,816,082 · App. 13/876,788 · Granted Nov 14, 2017

Variants of polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

Inventors: Matt Sweeney (Sacramento, CA); Mark Wogulis (Davis, CA)
Assignee: Novozymes, Inc.
C12N9/2437C12P19/14C12Y302/01004D21C5/005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,816,082
App. No.
13/876,788
Granted
Nov 14, 2017
Kind
B2
Abstract

The present invention relates to polypeptide having cellulolytic enhancing activity variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.

Claims (56)

1. A variant polypeptide of a parent GH61 polypeptide, comprising a substitution at one or more positions corresponding to positions 75, 77, 179, 181, and 183 of the full-length polypeptide of SEQ ID NO: 2, wherein the variant has cellulolytic enhancing activity, and wherein the parent GH61 polypeptide is selected from the group consisting of:

(a) a GH61 polypeptide having at least 95% sequence identity to the mature polypeptide of SEQ ID NO: 2; and

(b) a GH61 polypeptide encoded by a polynucleotide having at least 95% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 1 or the cDNA sequence thereof.

2. The variant of claim 1 , which comprises one or more substitutions selected from the group consisting of I75V, F77L, F179I, I181L, and I183V.

3. The variant of claim 1 , which comprises the substitutions I75V+F77L+F179I+I181L+I183V of the mature polypeptide of SEQ ID NO: 2.

4. An isolated polynucleotide encoding the variant of claim 1 .

5. An isolated recombinant host cell transformed with the polynucleotide of claim 4 .

6. A method of producing a variant, comprising:

(a) cultivating the recombinant host cell of claim 5 under conditions suitable for the expression of the variant; and

(b) recovering the variant.

7. A transgenic plant, plant part or plant cell transformed with the polynucleotide of claim 4 .

8. A method of producing the variant of claim 1 , comprising:

(a) transforming a plant or a plant cell with the polynucleotide encoding the variant;

(b) cultivating the transformed transgenic plant or a plant cell under conditions conducive for production of the variant; and

(c) recovering the variant from the cultivated and transformed transgenic plant or a plant cell.

9. A method for obtaining a variant, comprising introducing into a parent GH61 polypeptide a substitution at one or more positions corresponding to positions 75, 77, 179, 181, and 183 of SEQ ID NO: 2, wherein the variant has cellulolytic enhancing activity, and wherein the parent GH61 polypeptide is selected from the group consisting of:

(a) a GH61 polypeptide having at least 95% sequence identity to the mature polypeptide of SEQ ID NO: 2; and

(b) a GH61 polypeptide encoded by a polynucleotide having at least 95% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 1 or the cDNA sequence thereof.

10. A method for degrading a cellulosic material, comprising: treating the cellulosic material with an enzyme composition comprising the variant of claim 1 .

11. The method of claim 10 , further comprising recovering the degraded cellulosic material.

12. A method for producing a fermentation product, comprising:

(a) saccharifying a cellulosic material with an enzyme composition comprising the variant of claim 1 ;

(b) fermenting the saccharified cellulosic material with one or more fermenting microorganisms to produce the fermentation product; and

(c) recovering the fermentation product from the fermentation.

13. A method of fermenting a cellulosic material, comprising: fermenting the cellulosic material with one or more fermenting microorganisms, wherein the cellulosic material is saccharified with an enzyme composition comprising the variant of claim 1 .

14. The method of claim 13 , wherein the fermenting of the cellulosic material produces a fermentation product.

15. The method of claim 14 , further comprising recovering the fermentation product from the fermentation.

16. A detergent composition comprising the variant of claim 1 and a surfactant.

17. A whole broth formulation or cell culture composition comprising the variant of claim 1 .

18. The variant of claim 1 , wherein the parent GH61 polypeptide has at least 95% sequence identity to the mature polypeptide of SEQ ID NO: 2.

19. The variant of claim 1 , wherein the parent GH61 polypeptide comprises SEQ ID NO: 2 or the mature polypeptide thereof.

20. The variant of claim 1 , wherein the parent GH61 polypeptide consists of SEQ ID NO: 2 or the mature polypeptide thereof.

21. The variant of claim 1 , wherein the parent GH61 polypeptide is encoded by a polynucleotide having at least 95% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 1 or the cDNA sequence thereof.

22. The variant of claim 1 , wherein the number of substitutions is 1, 2, 3, 4, or 5 substitutions.

23. The variant of claim 1 , which comprises a substitution at a position corresponding to position 75.

24. The variant of claim 23 , wherein the substitution is Val.

25. The variant of claim 1 , which comprises a substitution at a position corresponding to position 77.

26. The variant of claim 25 , wherein the substitution is Leu.

27. The variant of claim 1 , which comprises a substitution at a position corresponding to position 179.

28. The variant of claim 27 , wherein the substitution is Ile.

29. The variant of claim 1 , which comprises a substitution at a position corresponding to position 181.

30. The variant of claim 29 , wherein the substitution is Leu.

31. The variant of claim 1 , which comprises a substitution at a position corresponding to position 183.

32. The variant of claim 31 , wherein the substitution is Val.

33. The variant of claim 1 , which comprises a substitution at two positions corresponding to any of positions 75, 77, 179, 181, and 183.

34. The variant of claim 1 , which comprises a substitution at three positions corresponding to any of positions 75, 77, 179, 181, and 183.

35. The variant of claim 1 , which comprises a substitution at four positions corresponding to any of positions 75, 77, 179, 181, and 183.

36. The variant of claim 1 , which comprises a substitution at each position corresponding to positions 75, 77, 179, 181, and 183.

37. The variant of claim 1 , which has increased thermal activity, increased thermostability, or a combination of increased thermal activity and increased thermostability.

38. The method of claim 10 , wherein the enzyme composition further comprises one or more enzymes selected from the group consisting of a cellulase, a polypeptide having cellulolytic enhancing activity, a hemicellulase, an expansin, an esterase, a laccase, a ligninolytic enzyme, a pectinase, a peroxidase, a protease, and a swollenin.

39. The method of claim 12 , wherein the enzyme composition further comprises one or more enzymes selected from the group consisting of a cellulase, a polypeptide having cellulolytic enhancing activity, a hemicellulase, an expansin, an esterase, a laccase, a ligninolytic enzyme, a pectinase, a peroxidase, a protease, and a swollenin.

40. The method of claim 13 , wherein the enzyme composition further comprises one or more enzymes selected from the group consisting of a cellulase, a polypeptide having cellulolytic enhancing activity, a hemicellulase, an expansin, an esterase, a laccase, a ligninolytic enzyme, a pectinase, a peroxidase, a protease, and a swollenin.

41. The variant of claim 1 , wherein the parent GH61 polypeptide has at least 96% sequence identity to the mature polypeptide of SEQ ID NO: 2.

42. The variant of claim 1 , wherein the parent GH61 polypeptide has at least 97% sequence identity to the mature polypeptide of SEQ ID NO: 2.

43. The variant of claim 1 , wherein the parent GH61 polypeptide has at least 98% sequence identity to the mature polypeptide of SEQ ID NO: 2.

44. The variant of claim 1 , wherein the parent GH61 polypeptide has at least 99% sequence identity to the mature polypeptide of SEQ ID NO: 2.

Assignments (1)
CONFIRMATORY LICENSE Recorded Sep 10, 2014
From: NOVOZYMES, INC.
To: ENERGY, UNITED STATES DEPARTMENT OF
Reel/Frame 033716/0486 →
Continuity (2)
Provisional Application 61388527 · Sep 30, 2010
Related Publication 20130227748A1 · Aug 29, 2013